Anti-Jo-1 autoantibody positive myositis:: Clinical features and survival in French Canadian patients.

被引：0
|
作者：
Troyanov, Y
Targoff, I
Tremblay, JL
Senécal, JL
机构：
[1] Univ Montreal, Montreal, PQ H3C 3J7, Canada
[2] Univ Oklahoma, Hlth Sci Ctr, VAMC, OMRF, Oklahoma City, OK USA
来源：
JOURNAL OF RHEUMATOLOGY | 2001年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
M57
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [31] Clinical and prognostic associations of anti-Jo-1 antibody levels in patients with antisynthetase syndrome
    Yang, Hongxia
    Chen, Qingning
    Sun, Chao
    Jin, Qiwen
    Zhang, Lining
    Liu, Qingyan
    Peng, Qinglin
    Wang, Guochun
    Lu, Xin
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [32] Symptoms spectrum and prognosis in patients with the idiopathic inflammatory myopathy with sera positive for anti-Jo-1 antibody in comparison with patients without presence of the myositis associated autoantibodies
    Mielnik, P
    Wiesik-Szewczyk, E
    Chwalinska-Sadowska, H
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 240 - 240
  • [33] The relevance of anti-Jo-1 autoantibodies in patients with definite dermatomyositis
    Vanessa Posener de Andrade
    Fernando Henrique Carlos De Souza
    Gustavo Luiz Behrens Pinto
    Samuel Katsuyuki Shinjo
    Advances in Rheumatology, 61
  • [34] The relevance of anti-Jo-1 autoantibodies in patients with definite dermatomyositis
    de Andrade, Vanessa Posener
    De Souza, Fernando Henrique Carlos
    Behrens Pinto, Gustavo Luiz
    Shinjo, Samuel Katsuyuki
    ADVANCES IN RHEUMATOLOGY, 2021, 61 (01)
  • [35] Periarticular calcinosis associated with anti-Jo-1 antibodies sine myositis.: Expanding the clinical spectrum of the antisynthetase syndrome
    Queiro-Silva, R
    Bañegil, I
    de Aberásturi, JRD
    Belzunegui-Otano, J
    González-Beneitez, C
    Figueroa-Pedrosa, M
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (06) : 1401 - 1404
  • [36] Anti-Jo-1 antibody positive polymyositis-successful therapy with leflunomide
    Lange, Uwe
    Piegsa, Manfred
    Mueller-Ladner, Ulf
    Strunk, Johannes
    AUTOIMMUNITY, 2006, 39 (03) : 261 - 264
  • [37] Clinical and serological aspects of patients with anti-Jo-1 antibodies an evolving spectrum of disease manifestations
    Schmidt, WA
    Wetzel, W
    Friedländer, R
    Lange, R
    Sörensen, HFK
    Lichey, HJ
    Genth, E
    Mierau, R
    Gromnica-Ihle, E
    CLINICAL RHEUMATOLOGY, 2000, 19 (05) : 371 - 377
  • [38] Successful therapy of anti-Jo-1 antibody positive polymyositis with leflunomide (Arava®)
    Piegsa, M
    Strunk, J
    Lange, U
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 240 - 240
  • [39] INTERSTITIAL LUNG-DISEASE AS THE PRESENTATION OF ANTI-JO-1 POSITIVE POLYMYOSITIS
    NASH, P
    SCHRIEBER, L
    WEBB, J
    CLINICAL RHEUMATOLOGY, 1987, 6 (02) : 282 - 286
  • [40] EXPERIENCES OF COVID19 DISEASE AND VACCINATION IN HUNGARIAN MYOSITIS PATIENTS: ANTI-JO-1 IS A RISK FACTOR FOR HOSPITALIZATION
    Nagy-Vincze, M.
    Beldi, T. G.
    Vincze, A.
    Szabo, K.
    Miltenyi-Szabo, B.
    Varga, Zs
    Griger, Z.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 467 - 467
12345